1. Home
  2. HQY vs GKOS Comparison

HQY vs GKOS Comparison

Compare HQY & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HQY
  • GKOS
  • Stock Information
  • Founded
  • HQY 2002
  • GKOS 1998
  • Country
  • HQY United States
  • GKOS United States
  • Employees
  • HQY N/A
  • GKOS N/A
  • Industry
  • HQY Business Services
  • GKOS Medical/Dental Instruments
  • Sector
  • HQY Consumer Discretionary
  • GKOS Health Care
  • Exchange
  • HQY Nasdaq
  • GKOS Nasdaq
  • Market Cap
  • HQY 8.5B
  • GKOS 7.4B
  • IPO Year
  • HQY 2014
  • GKOS 2015
  • Fundamental
  • Price
  • HQY $98.98
  • GKOS $138.39
  • Analyst Decision
  • HQY Buy
  • GKOS Strong Buy
  • Analyst Count
  • HQY 12
  • GKOS 12
  • Target Price
  • HQY $107.50
  • GKOS $135.08
  • AVG Volume (30 Days)
  • HQY 666.1K
  • GKOS 600.5K
  • Earning Date
  • HQY 12-09-2024
  • GKOS 11-04-2024
  • Dividend Yield
  • HQY N/A
  • GKOS N/A
  • EPS Growth
  • HQY 694.69
  • GKOS N/A
  • EPS
  • HQY 1.20
  • GKOS N/A
  • Revenue
  • HQY $1,099,131,000.00
  • GKOS $360,347,000.00
  • Revenue This Year
  • HQY $19.35
  • GKOS $22.68
  • Revenue Next Year
  • HQY $11.32
  • GKOS $24.98
  • P/E Ratio
  • HQY $82.52
  • GKOS N/A
  • Revenue Growth
  • HQY 17.19
  • GKOS 18.70
  • 52 Week Low
  • HQY $62.10
  • GKOS $59.22
  • 52 Week High
  • HQY $101.17
  • GKOS $145.84
  • Technical
  • Relative Strength Index (RSI)
  • HQY 68.11
  • GKOS 55.15
  • Support Level
  • HQY $94.32
  • GKOS $124.60
  • Resistance Level
  • HQY $101.17
  • GKOS $145.84
  • Average True Range (ATR)
  • HQY 2.94
  • GKOS 5.15
  • MACD
  • HQY 0.47
  • GKOS 0.30
  • Stochastic Oscillator
  • HQY 86.64
  • GKOS 64.92

About HQY HealthEquity Inc.

HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.

Share on Social Networks: